+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 10Years - 18Years
All Genders
ID07282613

Study of Weekly CagriSema Injections Compared to Placebo for Blood Sugar and Weight Control in Children and Adolescents with Type 2 Diabetes

Led by Novo Nordisk A/S · Updated on 2026-10-19

80

Participants Needed

58

Research Sites

29 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating how well a study medicine called CagriSema helps children and adolescents aged 10 to under 18 years with type 2 diabetes lower their blood sugar and body weight. This phase 3 clinical trial compares CagriSema to a placebo in a group of young participants, aiming to better understand its effects on diabetes management over about 15 months. Participants are randomly assigned to one of two groups in the first part one group receives weekly subcutaneous injections of CagriSema, which combines Cagrilintide B and Semaglutide I, while the other group receives a matching placebo injection. This phase lasts 26 weeks under double-blind conditions. In the second part, all participants receive CagriSema injections once weekly for another 26 weeks in an open-label phase. Throughout the study, participants undergo regular monitoring including blood tests to measure glycated hemoglobin HbA1c, body mass index BMI, continuous glucose monitoring, and various metabolic and safety assessments. Researchers track changes in blood sugar control, body weight, insulin dose, and other health markers from baseline through the treatment phases. The total study duration is approximately one year and three months, with careful evaluation of treatment effects and safety.

CONDITIONS

Brief Title

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

Research Team

N

Novo Nordisk

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here